Literature DB >> 16534842

Loss of heterozygosity of Kras2 gene on 12p12-13 in Chinese colon carcinoma patients.

Jun Wan1, Hong Li, Yuan Li, Mei-Ling Zhu, Po Zhao.   

Abstract

AIM: To study the loss of heterozygosity (LOH) on 12p12-13 in Chinese colon carcinoma patients.
METHODS: DNA was extracted from 10 specimens of cancer tissue, 10 specimens of adjacent tissue and 10 specimens of normal tissue, respectively. LOH of Kras2 gene was analyzed by polymerase chain reaction (PCR) and denaturing polyacrylamide gel electrophoresis using 11 microsatellite markers on 12p-12-13.
RESULTS: LOH of Kras gene was detected at least on one marker of 12p-12-13 in 30% (3/10) of adjacent tissue specimens. The highest frequency of LOH was identified on D12S1034 in 28.57% (2/7) of adjacent tissue specimens. LOH was detected at least on one marker of 12p12-13 in 60% (6/10) of carcinoma tissue specimens, the most frequent LOH was found on D12S1034 and D12S1591 in 42.86% (3/7) of carcinoma tissue specimens. LOH was detected in 30% (3/10) of carcinoma tissue specimens, 30% (3/10) of adjacent tissue specimens, and no signal in 1% (1/0) carcinoma tissue specimen. The occurrence of LOH did not correlate with sex, age, tumor size and lymph node metastasis.
CONCLUSION: Genomic instability may occur on 12p-12-13 of Kras2 gene in the development and progression of colon carcinoma. The high LOH of Kras2 gene may directly influence the transcription and translation of wild type Kras2 gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534842      PMCID: PMC4087893          DOI: 10.3748/wjg.v12.i7.1037

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  30 in total

1.  Detection of K-ras gene mutation in fecal samples from elderly large intestinal cancer patients and its diagnostic significance.

Authors:  Jun Wan; Zi-Qi Zhang; Wei-Di You; Hua-Kui Sun; Jian-Ping Zhang; Ya-Hong Wang; Yong-He Fu
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

2.  Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer.

Authors:  R Hirayama; S Sawai; Y Takagi; Y Mishima; N Kimura; N Shimada; Y Esaki; C Kurashima; M Utsuyama; K Hirokawa
Journal:  J Natl Cancer Inst       Date:  1991-09-04       Impact factor: 13.506

Review 3.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

Review 4.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.

Authors:  L Kozma; I Kiss; A Nagy; S Szakáll; I Ember
Journal:  Cancer Lett       Date:  1997-01-01       Impact factor: 8.679

6.  Role of tumor suppressor genes in transplacental lung carcinogenesis.

Authors:  L A Rollins; S Leone-Kabler; M G O'Sullivan; M S Miller
Journal:  Mol Carcinog       Date:  1998-03       Impact factor: 4.784

Review 7.  ras oncogenes in human cancer: a review.

Authors:  J L Bos
Journal:  Cancer Res       Date:  1989-09-01       Impact factor: 12.701

8.  Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents.

Authors:  Emanuela Barletta; Giuseppe Gorini; Paolo Vineis; Lucia Miligi; Laura Davico; Gabriele Mugnai; Stefania Ciolli; Franco Leoni; Marilena Bertini; Giuseppe Matullo; Adele Seniori Costantini
Journal:  Carcinogenesis       Date:  2003-12-19       Impact factor: 4.944

9.  K-ras gene point mutations and p21ras immunostaining in human ovarian tumors.

Authors:  A Semczuk; K Postawski; D Przadka; K Rozynska; A Wrobel; E Korobowicz
Journal:  Eur J Gynaecol Oncol       Date:  2004       Impact factor: 0.196

10.  Different genetic features associated with colon and rectal carcinogenesis.

Authors:  Milo Frattini; Debora Balestra; Simona Suardi; Maria Oggionni; Paola Alberici; Paolo Radice; Aurora Costa; Maria Grazia Daidone; Ermanno Leo; Silvana Pilotti; Lucio Bertario; Marco A Pierotti
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531

View more
  5 in total

Review 1.  Mitotic crossover--an evolutionary rudiment which promotes carcinogenesis of colorectal carcinoma.

Authors:  Branislav Rovcanin; Ivan Ivanovski; Olivera Djuric; Dimitrije Nikolic; Jelena Petrovic; Petar Ivanovski
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 2.  Mutant allele specific imbalance in oncogenes with copy number alterations: Occurrence, mechanisms, and potential clinical implications.

Authors:  Chih-Chieh Yu; Wanglong Qiu; Caroline S Juang; Mahesh M Mansukhani; Balazs Halmos; Gloria H Su
Journal:  Cancer Lett       Date:  2016-10-08       Impact factor: 8.679

Review 3.  Cancer and forensic microsatellites.

Authors:  Karen Page; Eleanor A M Graham
Journal:  Forensic Sci Med Pathol       Date:  2008-02-02       Impact factor: 2.007

4.  Tumour maintenance is mediated by eNOS.

Authors:  Kian-Huat Lim; Brooke B Ancrile; David F Kashatus; Christopher M Counter
Journal:  Nature       Date:  2008-03-16       Impact factor: 49.962

Review 5.  The role of wild type RAS isoforms in cancer.

Authors:  Bingying Zhou; Channing J Der; Adrienne D Cox
Journal:  Semin Cell Dev Biol       Date:  2016-07-13       Impact factor: 7.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.